Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Jan

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Cell Stem Cell|March 8, 2026
Off-the-shelf CAR natural killer progenitor cell therapies are built to lastNoor Radde, Max Jan
Trends in Pharmacological Sciences|May 1, 2022
SEAKER cells coordinate cellular immunotherapy with localized chemotherapyIsabel C Lane, Max Jan
Seminars in Hematology|January 17, 2017
Clonal hematopoiesisMax Jan, Benjamin L Ebert, Siddhartha Jaiswal
Nature Reviews. Clinical Oncology|March 3, 2021
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomideMax Jan, Adam S Sperling, Benjamin L Ebert
Trends in Cancer|February 14, 2024
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunologyGabriele J Kembuan, Joanna Y Kim, Marcela V Maus, et al.
Journal of Pathology Informatics|February 28, 2015
Development and validation of an app-based cell counter for use in the clinical laboratory settingAlexander C Thurman, Jessica L Davis, Max Jan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell markerMax Jan, Mark P Chao, Adriel C Cha, et al.
Science Translational Medicine|August 31, 2012
Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemiaMax Jan, Thomas M Snyder, M Ryan Corces-Zimmerman, et al.
Plos Genetics|September 13, 2011
The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXOGizem Rizki, Terri Naoko Iwata, Ji Li, et al.
Cancer Research|December 24, 2010
Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemiaMark P Chao, Ash A Alizadeh, Chad Tang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Cell Stem Cell|March 8, 2026
Off-the-shelf CAR natural killer progenitor cell therapies are built to lastNoor Radde, Max Jan
Trends in Pharmacological Sciences|May 1, 2022
SEAKER cells coordinate cellular immunotherapy with localized chemotherapyIsabel C Lane, Max Jan
Seminars in Hematology|January 17, 2017
Clonal hematopoiesisMax Jan, Benjamin L Ebert, Siddhartha Jaiswal
Nature Reviews. Clinical Oncology|March 3, 2021
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomideMax Jan, Adam S Sperling, Benjamin L Ebert
Trends in Cancer|February 14, 2024
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunologyGabriele J Kembuan, Joanna Y Kim, Marcela V Maus, et al.
Journal of Pathology Informatics|February 28, 2015
Development and validation of an app-based cell counter for use in the clinical laboratory settingAlexander C Thurman, Jessica L Davis, Max Jan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell markerMax Jan, Mark P Chao, Adriel C Cha, et al.
Science Translational Medicine|August 31, 2012
Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemiaMax Jan, Thomas M Snyder, M Ryan Corces-Zimmerman, et al.
Plos Genetics|September 13, 2011
The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXOGizem Rizki, Terri Naoko Iwata, Ji Li, et al.
Cancer Research|December 24, 2010
Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemiaMark P Chao, Ash A Alizadeh, Chad Tang, et al.
Pageof 4